PL364596A1 - Polipeptydy syntetazy tryptofanylo-tRNA użytecznew regulowaniu angiogenezy - Google Patents

Polipeptydy syntetazy tryptofanylo-tRNA użytecznew regulowaniu angiogenezy

Info

Publication number
PL364596A1
PL364596A1 PL02364596A PL36459602A PL364596A1 PL 364596 A1 PL364596 A1 PL 364596A1 PL 02364596 A PL02364596 A PL 02364596A PL 36459602 A PL36459602 A PL 36459602A PL 364596 A1 PL364596 A1 PL 364596A1
Authority
PL
Poland
Prior art keywords
angiogenesis
tryptophanyl
regulation
polypeptide
sequence
Prior art date
Application number
PL02364596A
Other languages
English (en)
Other versions
PL208008B1 (pl
Inventor
Paul Schimmel
Keisuke Wakasugi
Martin Friedlander
Original Assignee
The Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Scripps Research Institute filed Critical The Scripps Research Institute
Publication of PL364596A1 publication Critical patent/PL364596A1/pl
Publication of PL208008B1 publication Critical patent/PL208008B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y601/00—Ligases forming carbon-oxygen bonds (6.1)
    • C12Y601/01—Ligases forming aminoacyl-tRNA and related compounds (6.1.1)
    • C12Y601/01002—Tryptophan-tRNA ligase (6.1.1.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL364596A 2001-02-23 2002-02-22 Izolowany polipeptyd i jego zastosowanie, izolowany polinukleotyd, rekombinowany wektor, rekombinowana komórka gospodarza, kompozycja angiostatyczna i zestaw do hamowania neowaskularyzacji ocznej PL208008B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27095101P 2001-02-23 2001-02-23

Publications (2)

Publication Number Publication Date
PL364596A1 true PL364596A1 (pl) 2004-12-13
PL208008B1 PL208008B1 (pl) 2011-03-31

Family

ID=23033541

Family Applications (1)

Application Number Title Priority Date Filing Date
PL364596A PL208008B1 (pl) 2001-02-23 2002-02-22 Izolowany polipeptyd i jego zastosowanie, izolowany polinukleotyd, rekombinowany wektor, rekombinowana komórka gospodarza, kompozycja angiostatyczna i zestaw do hamowania neowaskularyzacji ocznej

Country Status (18)

Country Link
US (1) US20030017564A1 (pl)
EP (2) EP2080520A1 (pl)
JP (2) JP4361734B2 (pl)
KR (1) KR100869914B1 (pl)
CN (1) CN100486992C (pl)
AT (1) ATE420653T1 (pl)
AU (2) AU2002306558B2 (pl)
BR (1) BR0207449A (pl)
CA (1) CA2438273C (pl)
DE (1) DE60230860D1 (pl)
ES (1) ES2318063T3 (pl)
IL (3) IL157558A0 (pl)
MX (1) MXPA03007586A (pl)
NZ (1) NZ528193A (pl)
PL (1) PL208008B1 (pl)
RU (1) RU2297425C2 (pl)
WO (1) WO2002067970A1 (pl)
ZA (1) ZA200307383B (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8282921B2 (en) 2004-08-02 2012-10-09 Paul Glidden tRNA synthetase fragments

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903189B2 (en) * 2001-03-21 2005-06-07 The Scripps Research Institute Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
US20060104963A1 (en) * 2002-07-25 2006-05-18 The Scripps Research Institute Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
US7838290B2 (en) * 2002-07-25 2010-11-23 The Scripps Research Institute Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
US20060104962A1 (en) * 2002-07-25 2006-05-18 The Scripps Research Institute Transfected hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
ES2376866T3 (es) * 2002-07-25 2012-03-20 The Scripps Research Institute Células troncales hemotopoyéticas y procedimientos de tratamiento de las enfermedades oculares noeovasculares con las mismas
AU2005249586B2 (en) * 2004-06-04 2010-12-23 The Scripps Research Institute Compositions and methods for treatment of neovascular diseases
US20060079672A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Kits for modulating angiogenesis
US20060078553A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Diverse multi-unit complexes including a tRNA synthetase fragment
US20060024286A1 (en) * 2004-08-02 2006-02-02 Paul Glidden Variants of tRNA synthetase fragments and uses thereof
US20060078556A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Antibodies and epitopes specific to tRNA synthetase fragments
US20060079441A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Methods of modulating angiogenesis
US20060079472A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Methods for treating angiogenesis
US20060024288A1 (en) * 2004-08-02 2006-02-02 Pfizer Inc. tRNA synthetase fragments
US20060078886A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Business methods for modulating angiogenesis
US20060079673A1 (en) * 2004-08-02 2006-04-13 Paul Glidden Polynucleotides encoding tRNA synthetase fragments and uses thereof
US20060079474A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Analogs of tRNA synthetase fragments and uses thereof
US20060079473A1 (en) * 2004-10-07 2006-04-13 Paul Glidden Multi-unit complexes and uses thereof
DE102004054835A1 (de) * 2004-11-12 2006-05-24 VACUTEC Hochvakuum- & Präzisionstechnik GmbH Verfahren zur Herstellung einer Elektrode bzw. mehrpoligen Elektrodenanordnung sowie mehrpolige Elektrodenanordnung und Elektrode für eine mehrpolige Elektrodenanordnung
KR101244202B1 (ko) * 2005-02-24 2013-03-18 더 스크립스 리서치 인스티튜트 허혈성 망막 조직의 혈관재형성 및 이의 스크리닝 방법
KR100690802B1 (ko) * 2005-06-10 2007-03-09 엘지전자 주식회사 회동배터리커버를 구비한 이동통신 단말기
ES2622444T3 (es) * 2008-06-11 2017-07-06 Atyr Pharma, Inc. Actividad trombopoyética de polipéptidos tirosil-ARNt sintetasa
JP5756751B2 (ja) 2008-06-26 2015-07-29 エータイアー ファーマ， インコーポレイテッド 非正準的な生物学的活性を有するグリシル−ｔＲＮＡ合成酵素を含む組成物および方法
EP2403864B1 (en) 2009-02-27 2015-08-12 Atyr Pharma, Inc. Polypeptide structural motifs associated with cell signaling activity
DK3255146T3 (da) 2009-03-16 2019-08-19 Pangu Biopharma Ltd Præparater og fremgangsmåder omfattende histidyl-tRNA-synthetasesplejsningsvarianter med ikke-kanoniske biologiske aktiviteter
CN102449143B (zh) * 2009-03-31 2017-11-14 Atyr医药公司 包含具有非常规生物活性的天冬氨酰‑tRNA合成酶的组合物和方法
WO2011072266A2 (en) * 2009-12-11 2011-06-16 Atyr Pharma, Inc. Aminoacyl trna synthetases for modulating hematopoiesis
DK2509625T3 (en) 2009-12-11 2015-04-27 Atyr Pharma Inc Histidyl tRNA synthetases to reduce inflammation
US8828395B2 (en) 2009-12-11 2014-09-09 Atyr Pharma, Inc. Antibodies that bind tyrosyl-tRNA synthetases
AU2011248625B2 (en) 2010-04-26 2017-01-05 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
CN103096911B (zh) * 2010-04-27 2018-05-29 Atyr 医药公司 与异亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
EP2563382B1 (en) 2010-04-27 2017-06-07 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
CN103097524B (zh) 2010-04-28 2016-08-03 Atyr医药公司 与丙氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CA2797374C (en) 2010-04-29 2021-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
CN103118693B (zh) 2010-04-29 2017-05-03 Atyr 医药公司 与缬氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
US9068177B2 (en) 2010-04-29 2015-06-30 Atyr Pharma, Inc Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
WO2011140135A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
ES2623805T3 (es) 2010-05-03 2017-07-12 Atyr Pharma, Inc. Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de fenilalanil-alfa-ARNt sintetasas
CN103108655B (zh) 2010-05-03 2017-04-05 Atyr 医药公司 与丝氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CN103096925A (zh) 2010-05-03 2013-05-08 Atyr医药公司 与精氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CA2798301C (en) 2010-05-04 2020-09-15 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases
AU2011248101B2 (en) 2010-05-04 2016-10-20 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
US8945541B2 (en) 2010-05-14 2015-02-03 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
AU2011256366C1 (en) 2010-05-17 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
EP2575857B1 (en) 2010-06-01 2018-01-24 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
NZ603813A (en) 2010-07-12 2015-03-27 Atyr Pharma Inc Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
WO2012009289A2 (en) 2010-07-12 2012-01-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
CN103118695B (zh) 2010-07-12 2016-08-03 Atyr医药公司 与甘氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
US9029506B2 (en) 2010-08-25 2015-05-12 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-tRNA synthetases
EP2624857B1 (en) 2010-10-06 2017-08-02 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tryptophanyl trna synthetases
WO2013022982A2 (en) 2011-08-09 2013-02-14 Atyr Pharma, Inc. Pegylated tyrosyl-trna synthetase polypeptides
WO2013086228A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Pegylated aspartyl-trna synthetase polypeptides
WO2013086216A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Improved aspartyl-trna synthetases
AU2012368189B2 (en) 2011-12-29 2017-08-31 Atyr Pharma, Inc. Aspartyl-tRNA synthetase-Fc conjugates
JP6170077B2 (ja) 2012-02-16 2017-07-26 エータイアー ファーマ， インコーポレイテッド 自己免疫および炎症疾患を処置するためのヒスチジルｔＲＮＡ合成酵素
US20150119792A1 (en) * 2012-05-08 2015-04-30 The Regents Of The University Of California Light degradable drug delivery system for ocular therapy
JP6397479B2 (ja) 2013-03-15 2018-09-26 エータイアー ファーマ， インコーポレイテッド ヒスチジル−ｔＲＮＡシンテターゼＦｃコンジュゲート
PL3146057T3 (pl) * 2014-05-19 2020-12-14 F. Hoffmann-La Roche Ag Sposób wytwarzania polipeptydów
AU2018256435B2 (en) 2017-04-20 2025-03-13 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328803B1 (en) 1980-10-20 1994-01-11 Opthalmic Systems, Inc. Opthalmological procedures
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4517295A (en) 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
US5214080A (en) 1987-05-15 1993-05-25 Dainippon Ink And Chemicals, Inc. Process for producing nonaqueous dispersion-type resin
US5282851A (en) 1987-07-07 1994-02-01 Jacob Labarre Jean Intraocular prostheses
US5273751A (en) 1988-03-25 1993-12-28 Seymour Dubroff Composition for preventing clouding of paosterior capsule after extracapsular cataract eye surgery and method of performing cataract surgery
US5229127A (en) 1989-03-03 1993-07-20 Mckinzie James W Rapid miosis with control of intraocular pressure using a mixture of a cetylcholine and carbachol derivatives
US5278126A (en) 1989-03-31 1994-01-11 Ricoh Company, Ltd. Recording process and apparatus and recording medium in the same
US5116868A (en) 1989-05-03 1992-05-26 The Johns Hopkins University Effective ophthalmic irrigation solution
US5292362A (en) 1990-07-27 1994-03-08 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5273056A (en) 1992-06-12 1993-12-28 Alcon Laboratories, Inc. Use of combinations of viscoelastics during surgery
ATE473275T1 (de) * 2000-03-31 2010-07-15 Scripps Research Inst Menschliche aminoacyl-trna synthetase polypeptide zur regulation der angiogenese

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8282921B2 (en) 2004-08-02 2012-10-09 Paul Glidden tRNA synthetase fragments

Also Published As

Publication number Publication date
IL157558A (en) 2010-06-16
EP1377305A4 (en) 2005-02-09
CA2438273C (en) 2013-06-18
BR0207449A (pt) 2004-04-06
EP1377305A1 (en) 2004-01-07
EP1377305B1 (en) 2009-01-14
RU2003128420A (ru) 2005-02-20
KR100869914B1 (ko) 2008-11-21
CN100486992C (zh) 2009-05-13
IL201755A (en) 2015-01-29
EP2080520A1 (en) 2009-07-22
MXPA03007586A (es) 2003-12-11
CA2438273A1 (en) 2002-09-06
AU2007219318B2 (en) 2009-12-17
US20030017564A1 (en) 2003-01-23
JP2004532010A (ja) 2004-10-21
IL157558A0 (en) 2004-03-28
RU2297425C2 (ru) 2007-04-20
JP2009261409A (ja) 2009-11-12
PL208008B1 (pl) 2011-03-31
JP4448925B2 (ja) 2010-04-14
AU2007219318A1 (en) 2007-10-18
AU2002306558B2 (en) 2007-06-28
ZA200307383B (en) 2005-03-30
JP4361734B2 (ja) 2009-11-11
CN1527719A (zh) 2004-09-08
KR20030078935A (ko) 2003-10-08
NZ528193A (en) 2006-02-24
ES2318063T3 (es) 2009-05-01
DE60230860D1 (de) 2009-03-05
WO2002067970A1 (en) 2002-09-06
ATE420653T1 (de) 2009-01-15
HK1069322A1 (zh) 2005-05-20

Similar Documents

Publication Publication Date Title
IL157558A0 (en) TRYPTOPHANYL-tRNA SYNTHETASE DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
ATE435923T1 (de) Neue polynukleotide und polypeptide des erythropoietingens
ATE347591T1 (de) Thermostabile alpha-amylase
IL143034A0 (en) Human tslp dna and polypeptides
CA2324993A1 (en) Tadg-15: an extracellular serine protease overexpressed in breast and ovarian carcinomas
IL137037A0 (en) Acpl dna and polypeptides
PT1347056E (pt) Gene que codifica acetolactato-sintetase
BG101355A (en) Viral material and nucleotide fragments related to multiplesclerosis, for the diagnostics, prophylaxy and treatment of thisdisease
NZ534259A (en) A protein with homology to cysteine-rich secretory protein (CRISP) inhibitor
EP1037999A4 (en) POLYPEPTIDES AND NUCLEOTIDES PORPHYROMONAS GINGIVALIS
DE69937570D1 (de) Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
WO2002070549A3 (en) Chimeric polypeptides of serum albumin and uses related thereto
AU4945001A (en) Angiogenesis associated proteins, and nucleic acids encoding the same
WO1999041388A3 (en) Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides
PL345193A1 (en) Basb027 proteins and genes from moraxella catarrhalis
EP1219710A4 (en) POLYPEPTIDES AND GENES ENCODING THESE
DE69737321D1 (de) Polypeptide der menschlichen hyaluronan-synthase und dafür kodierende dns
GB2356864B (en) Novel polypeptide
ATE441865T1 (de) Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
WO1995006122A3 (de) Recombinante alternaria alternata allergene
ATE454452T1 (de) Basb118 polypeptid und polynukleotid aus moraxella catarrhalis
ATE360073T1 (de) Basb119 polypeptid und polynukleotid aus moraxella catarrhalis
EP0476670A3 (en) Cloned n-carbamoylsarcosine-amidohydrolase
WO2000077232A8 (en) Promoters from atlantic salmon
NZ528704A (en) Novel PRO717 polypeptides and nucleic acids encoding a 12 transmembrane polypeptide